Avidity Biosciences, Inc. (RNA)
71.60
+0.25
(+0.35%)
USD |
NASDAQ |
Dec 11, 16:00
71.60
0.00 (0.00%)
After-Hours: 20:00
Avidity Biosciences Free Cash Flow: -592.26M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novartis AG | 17.15B |
| Eli Lilly & Co. | 6.436B |
| Dyne Therapeutics, Inc. | -397.01M |
| Astria Therapeutics, Inc. | -120.32M |
| Intellia Therapeutics, Inc. | -412.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -156.17M |
| Cash from Investing (Quarterly) | -587.93M |
| Cash from Financing (Quarterly) | 850.37M |
| Free Cash Flow Per Share (Quarterly) | -1.138 |
| Free Cash Flow to Equity (Quarterly) | -201.72M |
| Free Cash Flow to Firm (Quarterly) | -156.88M |
| Free Cash Flow Yield | -6.30% |